A Step Toward the Exploration of Better Spirometric Parameters for Early Diagnosis of Pulmonary Dysfunction in Persons With Type 2 Diabetes Mellitus
- PMID: 35949805
- PMCID: PMC9356661
- DOI: 10.7759/cureus.26622
A Step Toward the Exploration of Better Spirometric Parameters for Early Diagnosis of Pulmonary Dysfunction in Persons With Type 2 Diabetes Mellitus
Abstract
Objectives: This study aims to determine the forced vital capacity (FVC) and slow vital capacity (SVC) along with other pulmonary functions in Indian diabetic patients for early diagnosis of pulmonary function reduction and to compare the ratios of forced expiratory volume in one second (FEV1) with FVC and SVC (FEV1/FVC and FEV1/SVC) in diabetic patients.
Materials and methods: A prospective observational study was carried out in the physiology department for two years after the approval of the institutional ethics committee. The study included 90 type 2 diabetes mellitus patients previously diagnosed by the physician and 90 age and sex-matched controls for spirometric tests. Medspiror having Helios 401 software (Recorders & Medicare Systems Pvt. Ltd., Panchkula, India) was used to assess the pulmonary function in all subjects. A comparison of dynamic pulmonary function parameters among non-diabetic and diabetic groups and non-obese vs. overweight/obese individuals of the diabetic group has been done. FEV1/FVC ratio vs. FEV1/SVC ratio comparison was conducted between the non-obese vs. the overweight/obese group in diabetic patients.
Results: A significant variation in FEV1 and FVC was observed in the type 2 diabetic group as compared to the non-diabetic group. However, in the case of type 2 diabetic subjects, FEV1/FVC ratio was almost constant in both BMI groups, whereas the FEV1/SVC ratio increased in the overweight/obese group.
Conclusion: Type 2 diabetes mellitus accounts for a predictive factor for worsening pulmonary function. SVC, particularly the FEV1/SVC ratio, can be an earlier diagnostic marker for pulmonary dysfunction in diabetic subjects as this ratio changes even with a constant FEV1/FVC ratio.
Keywords: body mass index (bmi); forced expiratory volume (fev1); forced vital capacity (fvc); slow vital capacity (svc); type 2 diabetes; type 2 diabetes mellites.
Copyright © 2022, Dash et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
The difference between slow and forced vital capacity increases with increasing body mass index: a paradoxical difference in low and normal body mass indices.Respir Care. 2015 Jan;60(1):113-8. doi: 10.4187/respcare.03403. Epub 2014 Oct 14. Respir Care. 2015. PMID: 25316893
-
Is the Slow Vital Capacity Clinically Useful to Uncover Airflow Limitation in Subjects With Preserved FEV1/FVC Ratio?Chest. 2019 Sep;156(3):497-506. doi: 10.1016/j.chest.2019.02.001. Epub 2019 Feb 12. Chest. 2019. PMID: 30768928
-
Comparison of Forced and Slow Vital Capacity Maneuvers in Defining Airway Obstruction.Respir Care. 2019 Jul;64(7):786-792. doi: 10.4187/respcare.06419. Epub 2019 Mar 19. Respir Care. 2019. PMID: 30890630
-
Assessment of Lung Functions by Spirometry in Diabetics with no Respiratory Complaints.J Assoc Physicians India. 2022 Apr;70(4):11-12. J Assoc Physicians India. 2022. PMID: 35443374
-
Pulmonary Pathology Among Patients with Type 2 Diabetes Mellitus: An Updated Systematic Review and Meta-analysis.Curr Diabetes Rev. 2020;16(7):759-769. doi: 10.2174/1573399815666190716130324. Curr Diabetes Rev. 2020. PMID: 31333139
Cited by
-
Diabetic Pneumopathy- A Novel Diabetes-associated Complication: Pathophysiology, the Underlying Mechanism and Combination Medication.Endocr Metab Immune Disord Drug Targets. 2024;24(9):1027-1052. doi: 10.2174/0118715303265960230926113201. Endocr Metab Immune Disord Drug Targets. 2024. PMID: 37817659 Review.
References
-
- WHO. Diabetes. [ Nov; 2022 ];https://www.who.int/health-topics/diabetes#tab=tab_1 2021 Diabetes,:2021–2010.
-
- Classification and diagnosis of diabetes: standards of medical care in diabetes—2018. American Diabetes Association. Diabetes Care. 2018;41:0–27. - PubMed
-
- COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Lim S, Bae JH, Kwon HS, Nauck MA. https://doi.org/10.1038/s41574-020-00435-4. Nat Rev Endocrinol. 2021;17:11–30. - PMC - PubMed
LinkOut - more resources
Full Text Sources